References
Aharon-Peretz J, Rosenbaum H, Gershoni-Baruch R (2004) Mutations in glucocerebrosidase gene and Parkinson’s disease in Ashkenazi Jews. N Engl J Med 351:1972–1977. doi:10.1056/NEJMoa033277
Mata IF, Samii A, Achneer SH, Roberts JW, Griffith A, Leis BC, Schellenberg GD, Sidransky E, Bird TD, Leverenz JB et al (2008) Glucocerebrosidase gene mutations: a risk factor for Lewy body disorders. Arch Neurol 65:379–382. doi:10.1001/archneurol.2007.68
Bras J, Paisan-Ruiz C, Guerreiro R, Ribeiro MH, Morgadinho A, Januario C, Sidransky E, Oliveira C, Singelton A (2007) Complete screening for glucocerebrosidase mutations in Parkinson’s disease patients from Portugal. Neurobiol Aging. doi:10.1016/neurobiolaging.2007.11.016
Bras J, Singleton A, Cookson MR, Hardy J (2008) Emerging pathways is genetic Parkinson’s disease: potential role of ceramide metabolism in Lewy body disease. FEBS J 275:5767–5773. doi:10.1111/j.1742-4658.2008.06709.x
Williams DR, Lees AJ (2009) Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges. Lancet Neurol 3:270–279. doi:10.1016/S1474-4422(09)70042-0
Tayebi N, Walker J, Stubblefield B, Orvisky E, LaMarca ME, Wong K, Rosenbaum H, Schiffmann R, Bembi B, Sidransky E (2003) Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism? Mol Genet Metab 79:104–109. doi:10.1016/S1096-7192(03)00071-4
Gutti U, Fung H-C, Hruska KS, LaMarca ME, Chen C-M, Wu Y-R, Sidransky E (2008) The need for appropriate genotyping strategies for glucocerebrosidase mutations in cohort with Parkinson’s disease. Arch Neurol 65(6):850–851. doi:10.1001/archneur.65.6.850
Goker-Alpan O, Lopez G, Vithayathil J, Davis J, Hallett M, Sidransky E (2008) The spectrum of parkinsonian manifestations associated with glucocerebrosidase mutations. Arch Neurol 65(10):1353–1357. doi:10.1001/archneur.65.10.1353
Segarane B, Li A, Paudel R, Scholz S, Neumann J, Lees A, Revesz T, Hardy J, Mathias CJ, Wood NW, Holton J, Houlden H (2009) Glucocerebrosidase mutations in 108 neuropathologically confirmed cases of multiple system atrophy. Neurology 72:1185–1186. doi:10.1212/01.wnl.0000345356.40399.eb
Abidhatia RM, Hatcher JF (2008) Altered lipid metabolism in brain injury and disorders. Subcell Biochem 49:241–268. doi:10.1007/978-1-4020-8831-5_9
Acknowledgments
This work was supported by the Polish Ministry of Science and Higher Education, Grant # N N402 4404 33.
Conflict of interest statement
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jamrozik, Z., Lugowska, A., Slawek, J. et al. Glucocerebrosidase mutations p.L444P and p.N370S are not associated with multisystem atrophy, progressive supranuclear palsy and corticobasal degeneration in Polish patients. J Neurol 257, 459–460 (2010). https://doi.org/10.1007/s00415-009-5363-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-009-5363-4